Behind the scenes


AIDA aims to develop and validate a multidisciplinary AI-powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric-inflammation and suggesting personalised therapeutics and monitoring.


We envision a new form of collaboration, beyond the public-private partnership model, in which participants from different countries or sectors exchange their data to create public value.

Data collaboratives form a sustainable answer to the problem that collaborative research and clinical innovation are generally limited to local, fragmented of limited quality, and research is progressing through ad-hoc collaborations on specific projects.


The Sooner. The Better.

Most cases of gastric cancer are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing gastric cancer at the pre-symptomatic stage, typically chronic infection with H. pylori, could significantly improve the outlook.

Spread the word!

In order to make our research accessible to everyone, you can easily download a free documentation of AIDA. No registration needed.


AIDA related news


Aida Consortium Holds General Assembly Meeting at i3S- Porto

The Aida Consortium recently convened its first general assembly meeting on March 4 and 5 at i3S-Porto. The gathering focused on reviewing the project’s progress and outlining future steps to advance the innovative AI diagnostic assistant for detecting lesions before


First Educational Session within the AIDA Project

We’re thrilled to share that our first educational session within the AIDA project, “Guidelines for management of patients with precancerous conditions and lesions in the stomach,” was a huge success! We had the privilege of having Prof. Mário-Dinis Ribeiro from